Design of a Cyclin G Associated Kinase (GAK)/Epidermal Growth Factor Receptor (EGFR) Inhibitor Set to Interrogate the Relationship of EGFR and GAK in Chordoma

被引：30
|
作者：
Asquith, Christopher R. M. [1 ,2 ]
Naegeli, Kaleb M. [3 ]
East, Michael P. [2 ]
Laitinen, Tuomo [4 ]
Havener, Tammy M. [3 ]
Wells, Carrow I. [1 ]
Johnson, Gary L. [2 ]
Drewry, David H. [1 ]
Zuercher, William J. [1 ,5 ]
Morris, David C. [3 ]
机构：
[1] Univ N Carolina, UNC Eshelman Sch Pharm, Struct Genom Consortium, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, UNC Catalyst Rare Dis, Chapel Hill, NC 27599 USA
[4] Univ Eastern Finland, Fac Hlth Sci, Sch Pharm, Kuopio 70211, Finland
[5] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 2019年 / 62卷 / 09期
基金：
加拿大创新基金会; 巴西圣保罗研究基金会;
关键词：
4-ANILINOQUINOLINES; EXPRESSION; MUTATIONS;
D O I：
10.1021/acs.jmedchem.9b00350
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
We describe the design of a set of inhibitors to investigate the relationship between cyclin G associated kinase (GAK) and epidermal growth factor receptor (EGFR) in chordoma bone cancers. These compounds were characterized both in vitro and using in cell target engagement assays. The most potent chordoma inhibitors were further characterized in a kinome-wide screen demonstrating narrow spectrum profiles. While we observed a direct correlation between EGFR and antiproliferative effects on chordoma, GAK inhibition appeared to have only a limited effect.
引用
收藏
页码：4772 / 4778
页数：7
相关论文
共 50 条
  • [21] The serine/threonine kinase cyclin G-associated kinase regulates epidermal growth factor receptor signaling
    Zhang, L
    Gjoerup, O
    Roberts, TM
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (28) : 10296 - 10301
  • [22] Tumor cell killing mechanisms of epidermal growth factor receptor (EGFR) antibodies are not affected by lung cancer-associated EGFR kinase mutations
    Peipp, Matthias
    Schneider-Merck, Tanja
    Dechant, Michael
    Beyer, Thomas
    van Bueren, Jeroen J. Lammerts
    Bleeker, Wim K.
    Parren, Paul W. H. I.
    van de Winkel, Jan G. J.
    Valerius, Thomas
    JOURNAL OF IMMUNOLOGY, 2008, 180 (06): : 4338 - 4345
  • [23] Semiology of skin toxicity associated with epidermal growth factor receptor (EGFR) inhibitors
    L. Peuvrel
    C. Bachmeyer
    Z. Reguiai
    J. B. Bachet
    T. André
    R. J. Bensadoun
    O. Bouché
    M. Ychou
    B. Dréno
    Supportive Care in Cancer, 2012, 20 : 909 - 921
  • [24] Hypermethylated Epidermal growth factor receptor (EGFR) promoter is associated with gastric cancer
    Weng, Xiaoling
    Zhang, Hong
    Ye, Junyi
    Kan, Mengyuan
    Liu, Fatao
    Wang, Ting
    Deng, Jiaying
    Tan, Yanfang
    He, Lin
    Liu, Yun
    SCIENTIFIC REPORTS, 2015, 5
  • [25] Hypermethylated Epidermal growth factor receptor (EGFR) promoter is associated with gastric cancer
    Xiaoling Weng
    Hong Zhang
    Junyi Ye
    Mengyuan Kan
    Fatao Liu
    Ting Wang
    Jiaying Deng
    Yanfang Tan
    Lin He
    Yun Liu
    Scientific Reports, 5
  • [26] Semiology of skin toxicity associated with epidermal growth factor receptor (EGFR) inhibitors
    Peuvrel, L.
    Bachmeyer, C.
    Reguiai, Z.
    Bachet, J. B.
    Andre, T.
    Bensadoun, R. J.
    Bouche, O.
    Ychou, M.
    Dreno, B.
    SUPPORTIVE CARE IN CANCER, 2012, 20 (05) : 909 - 921
  • [27] Safety and Tolerability of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors in Oncology
    Shah, Rashmi R.
    Shah, Devron R.
    DRUG SAFETY, 2019, 42 (02) : 181 - 198
  • [28] Absence of Mutations in the Epidermal Growth Factor Receptor (EGFR) Kinase Domain in Patients with Mesothelioma
    Velcheti, Vamsidhar
    Kasai, Yumi
    Viswanathan, Avinash K.
    Ritter, Jon
    Govindan, Ramaswamy
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (04) : 559 - 559
  • [29] Hepatotoxicity of epidermal growth factor receptor - tyrosine kinase inhibitors (EGFR-TKIs)
    Zhu, Lulin
    Yang, Xinxin
    Wu, Shanshan
    Dong, Rong
    Yan, Youyou
    Lin, Nengming
    Zhang, Bo
    Tan, Biqin
    DRUG METABOLISM REVIEWS, 2024, 56 (03) : 302 - 317
  • [30] Characterization of rare oncogenic mutations in the kinase domain of Epidermal Growth Factor Receptor (EGFR)
    Ruan, Zheng
    Katiyar, Samiksha
    Kannan, Natarajan
    FASEB JOURNAL, 2016, 30
12345